What's in Maoxiang Group Jilin Pharmaceutical Co., Ltd.'s pipeline?

Maoxiang Group Jilin Pharmaceutical Co., Ltd. has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Maoxiang Group Jilin Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Baxter Healthcare Corporation, Brigham and Women's Hospital, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Hellenic Society of Hematology, John van den Anker.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/maoxiang-group-jilin-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Maoxiang Group Jilin Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maoxiang Group Jilin Pharmaceutical Co., Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Acetaminophen tablets	Acetaminophen tablets	marketed	Analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system	Pain Management

Therapeutic area mix

Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baxter Healthcare Corporation · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · 1 shared drug class
Hellenic Society of Hematology · 1 shared drug class
John van den Anker · 1 shared drug class
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · 1 shared drug class
Mallinckrodt · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Maoxiang Group Jilin Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Maoxiang Group Jilin Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/maoxiang-group-jilin-pharmaceutical-co-ltd. Accessed 2026-05-18.